CLINICAL RESEARCH: CARDIAC IMAGING
Planimetry of Mitral Valve Stenosis by Magnetic Resonance Imaging
Behrus Djavidani, MD*,*,
Kurt Debl, MD ,
Markus Lenhart, MD*,
Johannes Seitz, MD*,
Christian Paetzel, MD*,
Franz X. Schmid, MD ,
Wolfgang R. Nitz, PhD*,
Stefan Feuerbach, MD*,
Günter Riegger, MD and
Andreas Luchner, MD
* Department of Diagnostic Radiology, University Hospital of Regensburg, Regensburg, Germany.
Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany.
Department of Cardiothoracic Surgery, University Hospital of Regensburg, Regensburg, Germany.
Manuscript received October 7, 2004;
revised manuscript received March 4, 2005,
accepted March 10, 2005.
* Reprint requests and correspondence: Dr. Behrus Djavidani, Department of Radiology, University Hospital of Regensburg, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany. (Email: behrus.djavidani{at}klinik.uni-regensburg.de).
OBJECTIVES: We sought to determine whether noninvasive planimetry of the mitral valve area (MVA) by magnetic resonance imaging (MRI) is feasible and reliable in patients with mitral stenosis (MS).
BACKGROUND: Accurate assessment of MVA is particularly important for the management of patients with valvular stenosis. Current standard techniques for assessing the severity of MS include echocardiography (ECHO) and cardiac catheterization (CATH).
METHODS: In 22 patients with suspected or known MS, planimetry of MVA was performed with a 1.5-T magnetic resonance scanner using a breath-hold balanced gradient echo sequence (true FISP). Data were compared with echocardiographically determined MVA (ECHO-MVA, n = 22), as well as with invasively calculated MVA by the Gorlin-formula at (CATH-MVA, n = 17).
RESULTS: The correlation between MRI- and CATH-MVA was 0.89 (p < 0.0001), and the correlation between MRI- and ECHO-MVA was 0.81 (p < 0.0001). The MRI-MVA slightly overestimated CATH-MVA by 5.0% (1.60 ± 0.45 cm2 vs. 1.52 ± 0.49 cm2, p = NS) and ECHO-MVA by 8.1% (1.61 ± 0.42 cm2 vs. 1.48 ± 0.42 cm2, p < 0.05). On receiver-operating characteristic curve analysis, a value of MRI-MVA below 1.65 cm2 indicated mitral stenosis (CATH-MVA 1.5 cm2), with a good sensitivity and specificity (89% and 75%, respectively).
CONCLUSIONS: Magnetic resonance planimetry of the mitral valve orifice in mitral stenosis offers a reliable and safe method for noninvasive quantification of mitral stenosis. In the clinical management of patients with mitral stenosis, it has to be considered that planimetry by MRI slightly overestimates MVA, as compared with MVA calculated echocardiographically and at catheterization.
|
Abbreviations and Acronyms
| | CATH = cardiac catheterization | | ECHO = echocardiography | | MRI = magnetic resonance imaging | | MS = mitral stenosis | | MVA = mitral valve area |
|
This article has been cited by other articles:

|
 |

|
 |
 
P. J. Cawley, J. H. Maki, and C. M. Otto
Cardiovascular Magnetic Resonance Imaging for Valvular Heart Disease: Technique and Validation
Circulation,
January 27, 2009;
119(3):
468 - 478.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Buchner, K. Debl, F. Poschenrieder, S. Feuerbach, G. A.J. Riegger, A. Luchner, and B. Djavidani
Cardiovascular Magnetic Resonance for Direct Assessment of Anatomic Regurgitant Orifice in Mitral Regurgitation
Circ Cardiovasc Imaging,
September 1, 2008;
1(2):
148 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Debl, B Djavidani, S Buchner, C Lipke, W Nitz, S Feuerbach, G Riegger, and A Luchner
Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis
Heart,
October 1, 2006;
92(10):
1447 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Messika-Zeitoun, J.-M. Serfaty, J.-P. Laissy, M. Berhili, E. Brochet, B. Iung, and A. Vahanian
Assessment of the Mitral Valve Area in Patients With Mitral Stenosis by Multislice Computed Tomography
J. Am. Coll. Cardiol.,
July 18, 2006;
48(2):
411 - 413.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
427 - 439.
[Full Text]
[PDF]
|
 |
|
|